Cargando…
P1144: PHASE 2 WAVELINE-004 STUDY: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
Autores principales: | Ozcan, Muhit, Song, Yuqin, Tae Lee, Seung, Mensah, Felix, Modi, Dipenkumar, Fossa, Alexander, Seog Kim, Won, Paszkiewicz-Kozik, Ewa, Sawalha, Yazeed, Gokmen Sevindik, Omur, Norasetthada, Lalita, Santoro, Armando, Pathiraja, Kumudu, Chakraborty, Samhita, Marinello, Patricia, Lavie, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430974/ http://dx.doi.org/10.1097/01.HS9.0000971472.03345.ef |
Ejemplares similares
-
P1200: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED OR REFRACTORY (R/R) NON-HODGKIN LYMPHOMA (NHL): UPDATED RESULTS FROM THE PHASE 1 WAVELINE-001 STUDY
por: Spurgeon, Stephen, et al.
Publicado: (2023) -
P1231: ZILOVERTAMAB VEDOTIN (MK-2140) FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA: THE PHASE 1 DOSE ESCALATION AND COHORT EXPANSION WAVELINE-001 STUDY OF AN ANTI-ROR1 ANTIBODY-DRUG CONJUGATE
por: Wang, M., et al.
Publicado: (2022) -
SAT-LB004 Therapeutic Potential of LPCN 1144 in NAFLD and NASH
por: Baker, Jonathan, et al.
Publicado: (2019) -
COLLABORATION FRAMEWORK AGREEMENT KN 2140 DG
por: THE EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH, CERN, et al.
Publicado: (2013) -
LPCN 1144 Resolves NAFLD in Hypogonadal Males
por: Albhaisi, Somaya, et al.
Publicado: (2020)